Lumos Pharma, Inc.
Detecting and treating growth hormone deficiency
Last updated:
Abstract:
Described herein is a new oral method for using MK-0677 for detecting growth hormone (GH) deficiency (GHD). Also described is a method of treating growth hormone (GH) deficiency (GHD) in children with a functional hypothalamic-pituitary GH axis.
Status:
Grant
Type:
Utility
Filling date:
20 Sep 2018
Issue date:
26 Jan 2021